Enhance protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA

Q. Ma, Q. Zhang, C. Wang (Chongqing, China; chongqing, Chile)

Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Session: Mechanisms of infection: what's new?
Session type: E-Communication Session
Number: 4779
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Q. Ma, Q. Zhang, C. Wang (Chongqing, China; chongqing, Chile). Enhance protection against nasopharyngeal carriage of Streptococcus pneumoniae elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA. Eur Respir J 2009; 34: Suppl. 53, 4779

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Pneumococcal vaccination: current and future issues
Source: Eur Respir J 2001; 18: 184-195
Year: 2001



Dynamics of serotypic composition of nasopharyngeal pneumococcal isolates in children pneumococcal nasopharyngeal colonization after the introduction of the vaccination program in Moscow
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020


Practicalities of human inoculation to establish experimental pneumococcal carriage in vaccine studies
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


Genetically modified Salmonella typhimurium (ST) for the intranasal vaccination against Mycobacterium tuberculosis (Mtb): In vitro and in vivo results from the sequella vaccine
Source: Eur Respir J 2002; 20: Suppl. 38, 11s
Year: 2002

Influenza and pneumococcal immunization initiates work
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001

Safety and immunogenicity of hemophilus influenzae type B conjugate vaccine in COPD
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Efficacy of vaccination to prevent pneumococcal infection in organized communities
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) and M. catarrhalis (Mcat) adjuvanted vaccines in adults
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010

Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018

Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly
Source: Eur Respir J 2010; 36: 608-614
Year: 2010



Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine
Source: Eur Respir J 2002; 20: 813-818
Year: 2002



Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020


New arguments for double action release active drugs in preparation for vaccination against pneumococcus among children with chronic sites of infection in nasopharynx
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004